Quality of reports of clinical trials submitted by the drug industry to the Finnish and Swedish control authorities E. Hemminki Originals Pages: 157 - 165
Moxaprindine in the acute treatment of ventricular arrhythmias in patients with cardiovascular disease J. StaessenH. Kesteloot Originals Pages: 167 - 172
Intravenous quinidine in congestive cardiomyopathy H. R. OchsE. GrubeR. Arendt Originals Pages: 173 - 176
Renal effects of SB 7505: A double-blind study G. F. MelloniG. M. MinojaP. Ghirardi Originals Pages: 177 - 180
Availability of isosorbide dinitrate, diazepam and chlormethiazole, from i. v. delivery systems P. A. CossumM. S. Roberts Originals Pages: 181 - 185
Pharmacokinetics of disopyramide in patients with imminent to moderate cardiac failure K. LandmarkJ. E. BredesenJ. P. Amlie Originals Pages: 187 - 192
Pharmacokinetics of oral timolol studied by mass fragmentography J. B. FourtillanP. CourtoisJ. Girault Originals Pages: 193 - 196
Pharmacokinetics and pharmacodynamics of propranolol stereoisomers in hyperthyroid patients K. TawaraK. KawashimaS. Yoshida Originals Pages: 197 - 203
Digoxin-associated thrombocytopaenia M. PirovinoE. E. OhnhausA. von Felten Originals Pages: 205 - 207
A single dose of azathioprine does not affect the pharmacokinetics of prednisolone following oral prednisone F. J. FreyF. LozadaB. M. Frey Originals Pages: 209 - 212
Plasma levels and pharmacokinetics of cyclofenil after oral administration to man L. Borgström Originals Pages: 213 - 216
Clinical pharmacokinetics of ketobemidone. Its bioavailability after rectal administration P. AndersonS. ArnérP. Hartvig Originals Pages: 217 - 223
In vitro release and in vivo serum fluoride levels and urinary excretion after different sodium fluoride tablets Ø. HasvoldT. Ekren Originals Pages: 225 - 230
